Composition containing IgE antibody

JP2026097971APending Publication Date: 2026-06-16KINGS COLLEGE LONDON

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: JP · JP
Patent Type: Applications
Current Assignee / Owner: KINGS COLLEGE LONDON
Filing Date: 2026-03-06
Publication Date: 2026-06-16

Application Information

Patent Timeline

06 Mar 2026

Application

16 Jun 2026

Publication

JP2026097971A

IPC: A61K39/395; C07K16/00; A61P35/00

CPC: A61K2039/505; A61K2039/545; A61P35/00; C07K16/28; C07K2317/24; C07K2317/52; C07K2317/732; C07K2317/94

AI Tagging

Application Domain

Antibody ingredients Immunoglobulins against cell receptors/antigens/surface-determinants

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Similar Technology Patents

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Smart Images

Figure 2026097971000005
Figure 2026097971000006
Figure 2026097971000007

Patent Text Reader

Abstract

The present invention provides compositions, particularly in unit dosage forms, that are suitable for isotyped immunoglobulin E (IgE) antibodies and are safe and effective in humans. [Solution] A pharmaceutical unit dose composition containing an antibody of isotype immunoglobulin E (IgE) is provided, the composition containing less than 50 mg of IgE antibody.

Need to check novelty before this filing date? Find Prior Art

Claims

[Claim 1] A pharmaceutical unit dose composition comprising an antibody of isotyped immunoglobulin E (IgE), wherein the composition comprises less than 50 mg of the IgE antibody.